MetaADEDB 2.0 @ LMMD
Ceftazidime anhydrous, (E)-
(ORFOPKXBNMVMKC-KZBLUZIOSA-N)
Structure
SMILES
O=C1[C@@H](NC(=O)/C(=N/OC(C(=O)O)(C)C)/c2csc(n2)N)[C@@H]2N1C(=C(CS2)C[n+]1ccccc1)C(=O)[O-]
Molecular Formula:
C22H22N6O7S2
Molecular Weight:
546.576
Log P:
-0.3892
Hydrogen Bond Acceptor:
14
Hydrogen Bond Donor:
3
TPSA:
244.76
CAS Number(s):
72558-82-8; 78439-06-2; 97148-38-4
Synonym(s)
1.
Ceftazidime anhydrous, (E)-
2.
Ceftazidime anhydrous
External Link(s)
PubChem Compound5484131
71587366
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1ShockFAERS: 6US FAERS
2Anaphylactic shockFAERS: 2US FAERS
3Anaphylactoid ReactionFAERS: 2US FAERS
4Depressed Level of ConsciousnessFAERS: 2US FAERS
5Disseminated Intravascular CoagulationFAERS: 2US FAERS
6Pancreatic enzymes increasedFAERS: 2US FAERS
7PancreatitisFAERS: 2US FAERS
8Pharmaceutical product complaintFAERS: 2US FAERS
9Pharyngolaryngeal PainFAERS: 2US FAERS
10Abdominal PainFAERS: 1US FAERS
11Alanine Aminotransferase IncreasedFAERS: 1US FAERS
12Aspartate Aminotransferase IncreasedFAERS: 1US FAERS
13BlepharitisFAERS: 1US FAERS
14Drug exposure during pregnancyFAERS: 1US FAERS
15Gamma-Glutamyltransferase IncreasedFAERS: 1US FAERS
16Memory impairmentFAERS: 1US FAERS
17Neutrophil count decreasedFAERS: 1US FAERS
18Oculomucocutaneous syndromeFAERS: 1US FAERS
19Oropharyngeal swellingFAERS: 1US FAERS
20PancytopeniaFAERS: 1US FAERS
21PneumoniaFAERS: 1US FAERS
22Septic ShockFAERS: 1US FAERS
23SwellingFAERS: 1US FAERS
24Urinary RetentionFAERS: 1US FAERS
25VasculitisFAERS: 1US FAERS
26White blood cell count decreasedFAERS: 1US FAERS
27prostatitisFAERS: 1US FAERS
28pseudomembranous colitisFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120237

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.